A detailed history of Janus Henderson Group PLC transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Janus Henderson Group PLC holds 53,500 shares of OCUL stock, worth $464,380. This represents 0.0% of its overall portfolio holdings.

Number of Shares
53,500
Holding current value
$464,380
% of portfolio
0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$4.2 - $8.69 $224,700 - $464,915
53,500 New
53,500 $365,000
Q2 2022

Aug 15, 2022

SELL
$3.01 - $5.22 $39,358 - $68,256
-13,076 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$4.83 - $7.35 $14 - $22
3 Added 0.02%
13,076 $64,000
Q4 2021

Feb 14, 2022

BUY
$6.16 - $12.07 $80,529 - $157,791
13,073 New
13,073 $91,000

Others Institutions Holding OCUL

About OCULAR THERAPEUTIX, INC


  • Ticker OCUL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,966,896
  • Market Cap $668M
  • Description
  • Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...
More about OCUL
Track This Portfolio

Track Janus Henderson Group PLC Portfolio

Follow Janus Henderson Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.